A promotional campaign has sparked a legal dispute between Spark Therapeutics and Bluebird Bio (BLUE) over the use of a single word: spark. As Bluebird works toward winning U.S. regulatory approval ...

Spark Therapeutics saw its share price tumble about 30% in early-morning trading after it reported mixed preliminary data this morning from a Phase I/II trial of its hemophilia A gene therapy ...

Spark Therapeutics, one of the first and now largest cell and gene therapy companies in the Philadelphia region, announced Friday that it was investing $575 million into a 500,000-square-foot ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio The wholesale acquisition cost of ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The former Spark Therapeutics ...

PHILADELPHIA, April 13, 2021 (GLOBE NEWSWIRE) -- Spark Therapeutics, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and a fully integrated, commercial gene therapy company dedicated to ...

Spark Therapeutics, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The company's goal is to produce a hemophilia A gene ...

Shares of Spark Therapeutics (NASDAQ: ONCE) were skyrocketing 120.1% as of 11:33 a.m. EST on Monday. The huge jump came after Roche Holdings (NASDAQOTH: RHHBY) announced that it was acquiring Spark ...

A $4.8 billion buyout by Roche sparks a celebration for the small biotech's investors. This deal can be considered a win-win-win proposition. Spark Therapeutics shareholders definitely win with an ...